Lv6
2320 积分 2021-12-05 加入
Endosome traffic in rheumatic diseases: mechanistic insights and therapeutic opportunities
11天前
已完结
How multispecific molecules are transforming pharmacotherapy
25天前
已完结
Central anorexigenic actions of bile acids are mediated by TGR5
27天前
已完结
Bezafibrate for primary biliary cholangitis: time to act on the evidence
28天前
已完结
Ivonescimab delays disease progression
28天前
已完结
Ocular toxicities of fibroblast growth factor receptor inhibitors: A review
1个月前
已完结
WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials
1个月前
已完结
Inhibitory immune checkpoints in cancer immunotherapy
1个月前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
3个月前
已完结
Combining VEGF and PD-1/PD-L1 inhibition in advanced hepatocellular carcinoma: clinical trials, real-world evidence, and future directions
3个月前
已完结
皖公网安备34019202002308
